Apriligen, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia (NCT07476183) | Apriligen, Inc. | 2026-04-16 |
Track Apriligen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.